FDA Cites Deficiencies in Veverimer NDA for Metabolic Acidosis in CKD
Veverimer is a non-absorbed, orally-administered polymer designed to treat metabolic acidosis in patients with CKD.
Miscellaneous Urogenital Disorders
Orphan Drug Status Granted to Potential Polycystic Kidney Disease Treatment
Autosomal dominant polycystic kidney disease (ADPKD) is caused by mutations of the PKD1 and PKD2 genes.
Recommendations Updated for Barrier Method Use Among Teens
American Academy of Pediatrics policy statement updated recommendations are presented relating to use of barrier methods for adolescents engaging in sexual activity.
Tolvaptan Lowers Kidney Stone Risk in ADPKD
Tolvaptan improves the urinary lithogenic risk profile of patients with autosomal dominant polycystic kidney disease, according to researchers.
CDC Updates List of Who Is at Highest Risk for COVID-19
Agency now says risk among adults increases steadily with age, and is not limited to those over 65.
Allopurinol Does Not Affect eGFR in Chronic Kidney Disease
And, serum urate lowering with allopurinol did not affect GFR in T1DM and diabetic kidney disease.
Co-Dispensing of Benzodiazepines and Opioids Dangerous in HD
Patients on hemodialysis who use opioids concurrently with a short-acting benzodiazepine are especially at risk for early death, a study found.
SARS-CoV-2 Identified in Semen of Men With COVID-19
SARS-CoV-2 present in 26.7% at acute stage of infection, 8.7% of recovering patients.
SGLT2 Inhibitors Linked to Reduced Risk for Serious Renal Events
Data from 3 countries showed drop in serious renal events with sodium-glucose cotransporter 2 inhibitors.
Furosemide Plus Sodium Chloride Not Helpful in Treating SIAD
Adding furosemide with or without sodium chloride to fluid restriction is not more effective than fluid restriction alone at correcting hyponatremia in patients with the syndrome of inappropriate antidiuresis, a study found.
